Back to Search
Start Over
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
- Source :
- GlobeNewswire. March 26, 2024
- Publication Year :
- 2024
-
Abstract
- Saint-Herblain (France), March 26, 2024 - https://www.globenewswire.com/Tracker?data=M-173rmZ8wTg2SDpcv_jkerBJ6lM8xDei-BFPAKPbjZjQWH9thTlEifDRbc_uqDYCWJHWCdrrYEwNLcG-GzXCw== (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the [...]
- Subjects :
- Valneva SE -- Product development -- Planning
Public health -- Health aspects
Clinical trials -- Health aspects
Vaccines -- Product development -- Planning
Company business planning
Banking, finance and accounting industries
Business
Ixiaro (Vaccine) -- Health aspects -- Product development
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.787685614